Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Publication Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Objectives of this study were to develop a population pharmacokinetic (PopPK) model for tacrolimus in…Certara2014年6月1日
The ISoP Standards and Best Practices Committee Publication The ISoP Standards and Best Practices Committee The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is…Certara2014年6月1日
The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Publication The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Certara2014年5月27日
Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Publication Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Model-based meta-analysis of dose response is a sophisticated method to guide dose and regimen selection.…Certara2014年5月21日
What Can We Learn from Dose Normalization? BlogKnowledge Base What Can We Learn from Dose Normalization? Dose normalization is a common calculation performed with pharmacokinetic parameters. The general process is to…Certara2014年5月19日
Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Publication Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Model-based drug development in oncology is still lagging despite a good momentum in the clinical…Certara2014年4月1日
Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results Publication Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results The motesanib phase III MONET1 study failed to show improvement in overall survival (OS) in…Certara2014年4月1日
Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction Publication Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction Herb–drug interaction predictions remain challenging. Physiologically based pharmacokinetic (PBPK) modeling was used to improve prediction…Certara2014年3月26日
Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Publication Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Azithromycin's extensive distribution to proinflammatory cells, including peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells…Certara2014年3月5日
Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies Publication Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies Thorough QT studies are typically conducted for drugs with systemic bioavailability and include a positive…Certara2014年3月1日